Matches in Wikidata for { <http://www.wikidata.org/entity/Q59216885> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q59216885 description "article" @default.
- Q59216885 description "wetenschappelijk artikel" @default.
- Q59216885 description "наукова стаття, опублікована у 2008" @default.
- Q59216885 name "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 name "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 type Item @default.
- Q59216885 label "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 label "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 prefLabel "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 prefLabel "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 P1433 Q59216885-FAA7B662-4740-48D5-A701-C7610D328BBD @default.
- Q59216885 P1476 Q59216885-390E815D-AE73-4AC7-B9E2-002B5959F579 @default.
- Q59216885 P2093 Q59216885-0D2BAA89-83E8-4BB4-ABE5-AC9300670118 @default.
- Q59216885 P2093 Q59216885-1BD501B2-40AA-4E65-ACCB-AE94A72A01CB @default.
- Q59216885 P2093 Q59216885-6A549DEB-0E16-4650-9F99-D981616C27A9 @default.
- Q59216885 P2093 Q59216885-6B7DE3C4-B768-48E9-A889-6E5AE9DB0991 @default.
- Q59216885 P2093 Q59216885-9F369786-49EC-45CF-86B5-FE47437A8E00 @default.
- Q59216885 P2093 Q59216885-C5C44B8A-E38A-4AA4-B0A4-2EE96B4467B1 @default.
- Q59216885 P2093 Q59216885-D1235557-ECF6-43A2-A297-88556FA02388 @default.
- Q59216885 P2093 Q59216885-EEFB7969-4DC2-4B9A-804E-7DDBE63FDE65 @default.
- Q59216885 P2093 Q59216885-F0C6DADF-C0D0-4876-90B1-707F60EEC34F @default.
- Q59216885 P2888 Q59216885-8A5E5D6A-F81C-4558-8475-05EBCBA7D5BA @default.
- Q59216885 P304 Q59216885-A20C5E69-E0E2-4C3F-BD34-86E8E2239E29 @default.
- Q59216885 P31 Q59216885-70A22D1E-42A3-458B-AE66-0454D5143D66 @default.
- Q59216885 P356 Q59216885-340FF82C-BA9C-4185-B7C9-F35D2511FA40 @default.
- Q59216885 P433 Q59216885-5877C390-C1E0-41ED-A5D1-853D96A13892 @default.
- Q59216885 P478 Q59216885-4BC069AD-0506-4BD6-A9C6-D322E33A9178 @default.
- Q59216885 P577 Q59216885-7BE0FC9D-D4AF-44AE-9F43-A40B4FDA1536 @default.
- Q59216885 P6179 Q59216885-E32E86EC-FF24-48C5-ABBA-6400A2E27427 @default.
- Q59216885 P921 Q59216885-1F98188E-D242-40EA-B4E1-C5B96AC75C9A @default.
- Q59216885 P921 Q59216885-E584BE24-F4E6-4C93-922A-997BB1691923 @default.
- Q59216885 P356 1758-2652-11-S1-P36 @default.
- Q59216885 P1433 Q6296158 @default.
- Q59216885 P1476 "Antiretroviral treatment use and HIV-RNA suppression rates for 877 European patients in the etravirine expanded access programme" @default.
- Q59216885 P2093 "A Castagna" @default.
- Q59216885 P2093 "AM Hill" @default.
- Q59216885 P2093 "E Florence" @default.
- Q59216885 P2093 "E Ribera" @default.
- Q59216885 P2093 "H Vanaken" @default.
- Q59216885 P2093 "R Ryan" @default.
- Q59216885 P2093 "S De Wit" @default.
- Q59216885 P2093 "S Marks" @default.
- Q59216885 P2093 "Y van Delft" @default.
- Q59216885 P2888 1758-2652-11-s1-p36 @default.
- Q59216885 P304 "P36" @default.
- Q59216885 P31 Q13442814 @default.
- Q59216885 P356 "10.1186/1758-2652-11-S1-P36" @default.
- Q59216885 P433 "Suppl 1" @default.
- Q59216885 P478 "11" @default.
- Q59216885 P577 "2008-01-01T00:00:00Z" @default.
- Q59216885 P6179 "1026492926" @default.
- Q59216885 P921 Q18123741 @default.
- Q59216885 P921 Q407954 @default.